Pharma Sales & Marketing (UCPMP/DPCO)

Strategic commercial planning extending brand revenue after patent expiration through reformulations, line extensions, and OTC switches.

Final conversational stage of a doctor detailing visit securing a firm prescribing commitment for specific patient profiles.

Strategy scheduling higher visit frequency (2-3 calls/month) for high-decile prescribers compared to low-decile doctors.

Ratio comparing retail chemist visits to doctor visits (standard benchmark is 1 chemist call per 2-3 doctor calls).

Commercial SOP establishing procedures and compensation credits for damaged or expired drug inventory returned by stockists.

Performance-based bonus structure rewarding representatives for achieving and exceeding monthly secondary sales targets.

Multi-stage institutional approval getting a new pharmaceutical brand accepted onto a major hospital’s procurement formulary.

Percentage of targeted doctors who convert from competitor brands to prescribing the representative’s promoted product.

Commercial terms defining number of days (typically 21 to 45 days) granted to authorized stockists to pay for delivered goods.

Geographic partitioning of sales territories based on doctor clinic concentration, chemist density, and travel efficiency.

Curated master list of high-potential prescribing physicians within a territory prioritized for regular promotional visits.

Technical dossier module detailing chemistry, manufacturing, and controls for drug substance (3.2.S) and drug product (3.2.P).

Microbiological agar diffusion assay measuring zone of inhibition diameter around stainless steel cylinders filled with antibiotic.

Key performance indicator measuring the average number of physical doctor calls completed per working day by a medical representative.

Mandatory daily activity log submitted via mobile CRM app recording doctor visits, product detailed, samples distributed, and chemist feedback.

Amperometric titration method using dual platinum electrodes where current flow halts or surges at equivalence.

Segmentation dividing prescribing physicians into 10 equal groups based on patient volume and prescription value potential.

Multidisciplinary hospital committee (physicians, clinical pharmacists, administrators) evaluating drug safety and efficacy for formulary addition.

Statutory price control order issued under Essential Commodities Act empowering NPPA to fix ceiling prices of scheduled formulations.

Inversion of a single chiral stereocenter in a molecule possessing multiple chiral centers (e.g. peptides, prostaglandins).

Consultative detailing technique linking drug chemical Feature (e.g. once-daily formulation) to Advantage (24h plasma levels) to Patient Benefit (better compliance).

Standard 0.1% peptone water rinse solution used to wash filter membranes in sterility testing before culturing.

Peptone water solution containing 0.1% Polysorbate 80 used to rinse membrane filters during sterility testing of oily products.

Government of India initiative establishing retail generic drug outlets providing quality generic medicines at 50-90% lower prices.

Senior sales role managing commercial relationships and formulary supply contracts with hospital networks and corporate healthcare chains.

Formal application submitted to the European Medicines Agency (EMA) or EU National Competent Authorities to market a medicinal product in European Union territories.

Non-promotional scientific peer holding doctoral degree (PharmD/MD/PhD) engaging in unbiased medical dialogue with Key Opinion Leaders (KOLs).

Validation verifying that sample product does not inhibit growth of test microorganisms during TAMC and TYMC tests.

Pre-approved monthly itinerary mapping out specific territory routes, daily doctor clinics, and chemist audits for each working day.

Official list of essential medications meeting priority health needs of Indian population, updated every 4-5 years by Ministry of Health.

Independent regulatory watchdog under Ministry of Chemicals & Fertilizers enforcing drug ceiling prices and monitoring availability.

Statutory DPCO regulation restricting manufacturers from increasing Maximum Retail Price (MRP) of non-scheduled drugs by > 10% in 12 months.

Technique resolving physician hesitations: acknowledging concern (Feel), normalizing experience (Felt), and presenting clinical proof (Found).

Detection of titration equivalence point via maximum rate of change in electromotive force (dE/dV).

Wholesale price at which pharmaceutical stockists sell medicines to retail pharmacy chemists.

Formula calculating invoice price from stockist to pharmacy: PTR = (MRP * 100) / (100 + Retailer Margin %) minus GST adjustments.

Ex-factory billing price at which the pharmaceutical manufacturer sells goods to the authorized stockist or distributor.

Net ex-factory billing price from pharmaceutical company/C&F agent to authorized stockists: PTS = PTR * (1 – Stockist Margin %).

Financial analysis decomposing revenue variances into changes in selling Price, sales Volume, and product portfolio Mix.

Primary sales represent billing from manufacturer/CFA to stockists; Secondary sales represent billing from stockists to retail chemists.

Systematic field audit conducted by medical representative at retail chemist shops adjacent to doctor clinics to monitor prescribing habits.

Discipline optimizing pharmaceutical sales operations through territory design, doctor profiling, incentive management, and KPI tracking.

Mandatory legal record tracking lot numbers, dates, doctor signatures, and quantities of promotional drug samples distributed.

Monthly auditing matching stockist opening inventory plus primary purchases minus closing inventory against claimed chemist sales.

Provision of Indian Income Tax Act requiring 10% TDS deduction on value of any benefit or perquisite (> INR 20,000/year) given to doctors.

Pre-sterilized, disposable dual-canister filtration unit preventing adventitious laboratory airborne contamination during sterility tests.

Actual purchase and consumption of medicines by final end-consumer patients across retail pharmacy counters.

Government policy capping excessive distributor and retailer profit margins between ex-factory price and Maximum Retail Price (MRP).

Quantitative bioassay measuring light absorbance caused by bacterial growth inhibition in liquid broth by antibiotics.

Mandatory restriction limiting free promotional drug samples to maximum 12 packs per registered medical practitioner per calendar year.

Statutory ceiling capping total commercial monetary value of drug samples distributed at maximum 1.5% of company’s domestic annual turnover.

Mandatory statutory ethical code governing pharmaceutical marketing in India notified in 2024.

Statutory ethical marketing code issued by Department of Pharmaceuticals, Government of India, regulating drug promotion.

Structured logical layout of printed or e-detailing tablet presentation: Problem -> Disease Burden -> Product MoA -> Clinical Efficacy -> Safety -> Dosage.